Economic evaluation (EE) studies have been undertaken in dentistry since the late 20th century because economic data provide additional information to policy makers to develop guidelines and set future direction for oral health services. The objectives of this study were to assess the methodological quality of EEs in oral health. Electronic searching of Ovid MEDLINE, the Cochrane Library, and the NHS Economic Evaluation Database from 1975 to 2013 were undertaken to identify publications that include costs and outcomes in dentistry. Relevant reference lists were also searched for additional studies. Studies were retrieved and reviewed independently for inclusion by 3 authors. Furthermore, to appraise the EE methods, 1 author applied the Drummond 10-item (13-criteria) checklist tool to each study. Of the 114 publications identified, 79 studies were considered full EE and 35 partial. Twenty-eight studies (30%) were published between the years 2011 and 2013. Sixty-four (53%) studies focused on dental caries prevention or treatment. Median appraisal scores calculated for full and partial EE studies were 11 and 9 out of 13, respectively. Quality assessment scores showed that the quality of partial EE studies published after 2000 significantly improved (P = 0.02) compared to those published before 2000. Significant quality improvement was not found in full EE studies. Common methodological limitations were identified: absence of sensitivity analysis, discounting, and insufficient information on how costs and outcomes were measured and valued. EE studies in dentistry increased over the last 40 y in both quantity and quality, but a number of publications failed to satisfy some components of standard EE research methods, such as sensitivity analysis and discounting.
AghaZLofgrenRPVan RuiswykJV. 2005. Is antibiotic prophylaxis for bacterial endocarditis cost-effective?Med Decis Making. 25(3):308–320.
2.
BhuridejPKuthyRAFlachSDHellerKEDawsonDVKanellisMJDamianoPC. 2007. Four-year cost-utility analyses of sealed and nonsealed first permanent molars in Iowa Medicaid-enrolled children. J Public Health Dent. 67(4):191–198.
3.
BriggsAHGrayAM. 1999. Handling uncertainty in economic evaluations of healthcare interventions. BMJ. 319(7210):635–638.
4.
BrunsonDO’ConnellJMAnselmoTSullivanPW. 2005. Costs and savings associated with community water fluoridation programs in Colorado. Prev Chronic Dis. 2 Spec No:A06.
5.
CampainACMariñoRJWrightFACHarrisonDBaileyDLMorganMV. 2010. The impact of changing dental needs on cost savings from fluoridation. Aust Dent J. 55(1):37–44.
6.
CavinessCCantorSBAllenCHWardMA. 2004. A cost-effectiveness analysis of bacterial endocarditis prophylaxis for febrile children who have cardicac lesions and undergo urinary catheterization in the emergency department. Pediatrics. 113(5):1291–1296.
7.
CiketicSHayatbakhshMRDoranCM. 2010. Drinking water fluoridation in South East Queensland: a cost-effectiveness evaluation. Health Promot J Austr. 21(1):51–56.
8.
CobiacLJVosT. 2012. Cost-effectiveness of extending the coverage of water supply fluoridation for the prevention of dental caries in Australia. Community Dent Oral Epidemiol. 40(4):369–376.
9.
CunninghamSJSculpherMSassiFMancaA. 2003. A cost-utility analysis of patients undergoing orthognathic treatment for the management of dentofacial disharmony. Br J Oral Maxillofac Surg. 41(1):32–35.
10.
DavenportCElleyKSalasCTaylor-WeetmanCLFry-SmithABryanSTaylorR. 2003. The clinical effectiveness and cost-effectivenes of routine dental checks: a systematic reveiw and economic evaluation. Health Technol Assess. 7(7):iii–v, 1–127.
11.
DedhiaRCSmithKJJohnsonJTRobertsM. 2011. The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: a Markov decision analysis approach. Laryngoscope. 121(5):952–960.
12.
DeeryC. 1999. The economic evaluation of pit and fissure sealants. Int J Paediatr Dent. 9(4):235–241.
13.
DevereuxRBFraryCJKramer-FoxRRobertsRBRuchlinHS. 1994. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol. 74(10):1024–1029.
14.
DoesselDP. 1985. Cost-benefit analysis of water fluoridation in Townsville, Australia. Community Dent Oral Epidemiol. 13(1):19–22.
15.
DrummondMBarbieriMCookJGlickHALisJMalikFReedSDRuttenFSculpherMSeverensJ. 2009. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health. 12(4):409–418.
16.
DrummondMBrandtALuceBRoviraJ. 1993. Standardizing methodologies for economic evaluation in health care: practice, problems, and potential. Int J Technol Assess. 9(1):26–93.
17.
DrummondMMancaASculpherM. 2005. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care. 21(2):165–171.
18.
DrummondMF. 1987. Economic appraisal of health technology in the European community. Brussels (Belgium): Oxford University Press.
19.
DrummondMFJeffersonTO. 1996. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 3(752):275–283.
20.
DrummondMFSchwartzJSJönssonBLuceBRNeumannPJSiebertU. 2008. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 24(3):244–258.
21.
DrummondMFSculpherMJTorranceGWO’BrienBStoddartGL. 2005. Method for the economic evaluation of health care programmes. New York (NY): Oxford University Press.
22.
DrummondMFTorranceGWStoddartGL. 1987. Methods for the economic evaluation of health care programmes. Oxford (UK): Oxford University Press.
23.
EversSGoossensMde VetHVan TulderMAmentA. 2005. Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria. Int J Technol Assess. 21(2):240–245.
24.
GouldIMBuckinghamJK. 1993. Cost effectiveness of prophylaxis in dental practice to prevent infective endocarditis. Brit Heart J. 70(1):79–83.
25.
GriffinSOJonesKTomarSL. 2001. An economic evaluation of community water fluoridation. J Public Health Dent. 61(2):78–86.
26.
GuyattGHOxmanADVistGEKunzRFalck-YtterYAlonso-CoelloPSchünemannHJ; GRADE Working Group. 2008. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 336(7650):924–926.
27.
HeydeckeGPenrodJRTakanashiYLundJPAlE. 2005. Cost-effectiveness of mandibular two-implant overdentures and conventional dentures in the edentulous elderly. J Dent Res. 84(9):794–799.
28.
John-BaptisteAYeungMWLeungVVan Der VeldeGKrahnM. 2012. Cost effectiveness of hepatitis C-related interventions targeting substance users and other high-risk groups: a systematic review. Pharmacoeconomics. 30(11):1015–1034.
29.
KällestålCNorlundASöderBNordenramGDahlgrenHPeterssonLgLagerlöfFAxelssonSLingströmPMejàreI. 2003. Economic evaluation of dental caries prevention: a systematic review. Acta Odontol Scand. 61(6):341–346.
30.
MariñoRJKhanARMorganM. 2013. Systematic review of publications on economic evaluations of caries prevention programs. Caries Res. 47(4):265–272.
31.
National Institute for Clinical Excellence. 2000. Guidance on the extraction of wisdom teeth. London (UK): National Collaborating Centre for Acute Care.
32.
National Institute for Clinical Excellence. 2004. Dental recall: recall interval between routine dental examination. London (UK): National Collaborating Centre for Acute Care.
33.
National Institute for Clinical Excellence. 2008. Prophylaxis against infective endocarditis: Antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. London (UK): National Institute for Health and Clinical Excellence.
34.
NiessenLCDouglassCW. 1984. Theoretical considerations in applying benefit-cost and cost-effectiveness analyses to preventive dental programs. J Public Health Dent. 44(4):156–168.
35.
Organization for Economic Co-operation and Development. 2010. Health care systems: Getting more value for money. Economics Department policy notes. No. 2. Paris (France): Organization for Economic Co-operation and Development.
36.
O’RourkeCAAttrillMHollowayPJ. 1988. Cost appraisal of a fluoride tablet programme to Manchester primary schoolchildren. Community Dent Oral Epidemiol. 16(6):341–344.
37.
OxmanAD. 2004. Grading quality of evidence and strength of recommendations. BMJ. 328:1490–1494.
38.
RuttenF. 1996. Economic evaluation and health care decision-making. Health Policy. 36(3):215–229.
39.
SalkeldGDaveyPArnoldaG. 1995. A critical review of health-related economic evaluations in Australia: implications for health policy. Health Policy. 31(2):111–125.
40.
SBU. 2002. Prevention of dental caries: a systematic review. Report No. 161. Stockholm (Sweden): Swedish Council on Technology Assessment in Health Care. p 1–26.
41.
SeverensJLMilneRJ. 2004. Discounting health outcomes in economic evaluation: the ongoing debate. Value Health. 7(4):397–401.
42.
ShariatiBMacenteeMIYazdizadehM. 2013. The economics of dentistry: a neglected concern. Community Dent Oral Epidemiol. 41(5):385–394.
43.
ShemiltIMugfordMByfordSDrummondMEisensteinEKnappMMallenderJMcDaidDValeLWalkerD. 2011. 15.5.2 Critical appraisal of methodological quality. In HigginsJPGreenS, editors. Cochrane handbook for systematic reviews of interventions (version 5.1.0). Oxford (UK): Cochrane Collaboration.
44.
SimoensS. 2010. Use of economic evaluation in decision making evidence and recommendations for improvement. Drugs. 70(15):1917–1926.
45.
SongFO’MearaSWilsonPGolderSKleijnenJ. 2000. The effectiveness and cost-effectiveness of prophylactic removal of wisdom teeth. Health Technol Assess. 4(15):1–55.
46.
SpeightPMPalmerSMolesDRDownerMCSmithDHHenrikssonMAugustovskiF. 2006. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess. 10(14):1–144, iii–iv.
47.
SpliethCHFlessaS. 2008. Modelling lifelong costs of caries with and without fluoride use. Eur J Oral Sci. 116(2):164–169.
48.
StephenKWCampbellD. 1978. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind Trial. Br Dent J. 144(7):202–206.
49.
TorranceGWZipurskyAA. 1984. Cost-effectiveness of antepartum prevention of Rh immunization. Clin Perinatol. 11(2):267–281.
50.
TsevatJDurand-ZaleskiIPaukerSG. 1989. Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. Am J Public Health. 79(6):739–743.
51.
WalkerDGWilsonRFSharmaRBridgesJNiessenLBassEBFrickK. 2012. Best practices for conducting economic evaluations in health care: a systematic review of quality assessment tools. AHRQ publication No. 12(13)-EHC132-EF. Rockville (MD): Agency for Healthcare Research and Quality.
52.
WeinsteinMCStasonWB. 1977. Foundations of cost-effectiveness analysis for health and medical practices. New Engl J Med. 296(13):716–721.
53.
WilliamsAH. 1985. Economics of coronary artery bypass grafting. Br Med J (Clin Res Ed). 291(6491):326–329.
54.
WongWPFengJPweeKHLimJ. 2012. A systematic review of economic evaluations of cardiac rehabilitation. BMC Health Serv Res. 12:243.
55.
WrayDRuizFRicheyRStokesT; Guideline Development Group. 2008. Prophylaxis against infective endocarditis for dental procedures-summary of the NICE guideline. Br Dent J. 204(10):555–557.
56.
WrightJCBatesMNCutressTLeeM. 2001. The cost-effectiveness of fluoridating water supplies in New Zealand. Aust N Z J Public Health. 25(2):170–178.
57.
ZelleSGBaltussenRM. 2013. Economic analyses of breast cancer control in low- and middle-income countries: a systematic review. Syst Rev. 2:20.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
